You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

OSI

Showing 1 - 25 of 442
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Liver Cancer Trial in Houston (Bevacizumab, Erlotinib)

Completed
Has Results
  • Liver Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 3, 2022

NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

Not yet recruiting
  • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
  • (no location specified)
Aug 27, 2023

Non Small Cell Lung Cancer, Lung Cancer Trial in Los Angeles (Osimertinib, Carotuximab)

Recruiting
  • Non Small Cell Lung Cancer
  • Lung Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 20, 2022

Lung Cancer Trial in New Haven, Houston (Erlotinib, AZD6244, MK-2206)

Completed
Has Results
  • Lung Cancer
  • New Haven, Connecticut
  • +1 more
Dec 14, 2021

Total Knee Arthroplasty (TKA) Trial (Knee Glider)

Not yet recruiting
  • Total Knee Arthroplasty (TKA)
  • Knee Glider
  • (no location specified)
Apr 6, 2022

Vitrectomy, Cataract Trial in Paris (Objective Scatter Index (OSI), Average Lens Density (ALD))

Recruiting
  • Vitrectomy
  • Cataract
  • Objective Scatter Index (OSI)
  • Average Lens Density (ALD)
  • Paris, France
    Hôpital Fondation A. de Rothschuld
Oct 4, 2021

NSCLC, Brain Cancer Trial in Tucson, Houston (Tarceva (Erlotinib HCl), Radiation Therapy)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Brain Cancer
  • Tarceva (Erlotinib hydrochloride)
  • Radiation Therapy
  • Tucson, Arizona
  • +1 more
Sep 14, 2021

Veterans Family, Military Family, Trauma, Psychological Trial in Dartmouth (Pilot psychoeducation program, Program evaluation)

Completed
  • Veterans Family
  • +2 more
  • Pilot psychoeducation program
  • Program evaluation
  • Dartmouth, Nova Scotia, Canada
    Nova Scotia OSI Clinic
Jul 30, 2021

Lung Cancer Trial in Houston (DOTAP:Chol-TUSC2, Erlotinib, Dexamethasone)

Terminated
  • Lung Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 11, 2022

NSCLC Trial in United States (bevacizumab, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Galloway, New Jersey
  • +6 more
Jun 17, 2022

Hearing Loss Trial in Gladesville, Carlton, Hong Kong (Active Osseointegrated Steady-State Implant System (OSI))

Completed
  • Hearing Loss
  • Active Osseointegrated Steady-State Implant System (OSI)
  • Gladesville, New South Wales, Australia
  • +2 more
Mar 24, 2022

Cirrhosis, Hepatocellular Carcinoma Trial in United States (Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis)

Active, not recruiting
Has Results
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Jacksonville, Florida
  • +5 more
Feb 24, 2022

EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Trial in Worldwide (Atezolizumab, Bevacizumab, Carboplatin)

Active, not recruiting
  • EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
  • Großhansdorf, Germany
  • +17 more
Jan 12, 2023

Head Neck Cancer Trial in Houston (drug, other, behavioral)

Active, not recruiting
  • Head and Neck Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 31, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Recurrent NSCLC Trial in Sacramento, San Francisco (INC280, erlotinib HCl)

Completed
  • Recurrent Non-small Cell Lung Cancer
  • Sacramento, California
  • +1 more
Oct 11, 2021

Hearing Loss Trial in Gladesville, Melbourne, Hong Kong (Osia 2 system)

Completed
Has Results
  • Hearing Loss
  • Osia 2 system
  • Gladesville, Australia
  • +2 more
Aug 17, 2021

Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric

Completed
Has Results
  • Unresectable Adenocarcinoma of the Esophagus
  • +3 more
  • Los Angeles, California
  • +1 more
Sep 3, 2021

Breast Cancer Trial in Los Angeles (trastuzumab, erlotinib HCl)

Completed
Has Results
  • Breast Cancer
  • trastuzumab
  • erlotinib hydrochloride
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Sep 17, 2020

Polycythemia Vera Trial in Oklahoma City (Erlotinib)

Terminated
Has Results
  • Polycythemia Vera
  • Oklahoma City, Oklahoma
    University of Oklahoma Health Sciences Center
Aug 7, 2020

Non Small Cell Lung Cancer Metastatic Trial in Worldwide (Osimertinib, Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Dublin, Ireland
  • +24 more
Aug 23, 2022

Lung Cancer Trial in Cleveland (drug, procedure, radiation)

Completed
Has Results
  • Lung Cancer
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 17, 2020

Non-Small-Cell Lung Carcinoma Trial in Boston (OSI-774 (Tarceva))

Completed
  • Non-Small-Cell Lung Carcinoma
  • OSI-774 (Tarceva)
  • Boston, Massachusetts
  • +1 more
Apr 1, 2020

Brain Cancer Trial in Basking Ridge, Commack, New York (erlotinib, Cytoreductive Surgery)

Completed
  • Brain Cancer
  • Basking Ridge, New Jersey
  • +3 more
Jan 6, 2021